HX BIO VENTURES

Hx Bio Ventures invests in early-stage companies developing next-generation biologics. It is Hxโ€™s mission to help exceptional entrepreneurs building the next generation of great biotech companies. With a clear focus on & know-how in drug development and their manufacturability, Hx Bio intends to partner with innovative biotech companies looking to derisk their development processes early on.

#SimilarOrganizations #Financial #More

HX BIO VENTURES

Status:
Active


Similar Organizations

enzyvant-sciences-logo

Enzyvant Sciences

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.

rittenhouse-ventures-logo

Rittenhouse Ventures

Rittenhouse Ventures invests in small rounds of capital-efficient Early-Growth stage companies primarily in Healthcare and Pharma IT.

ufi-ventures-logo

Ufi Ventures

Ufi Ventures invests in in seed-stage companies that are building digital technologies.

Investments List

Date Company Article Money raised
2021-10-14 Abalos Therapeutics Hx Bio Ventures investment in Series A - Abalos Therapeutics 31 M EUR

More informations about "Hx Bio Ventures"

Hx Bio Ventures - Crunchbase Investor Profile & Investments

Oct 14, 2021 Hx Bio Ventures invests in early-stage biotechnology companies, focusing on science and engineering sectors, with a geographical emphasis on Essen, Nordrhein โ€ฆSee details»

Hx Bio Ventures - Investments, Portfolio & Company Exits

Oct 14, 2021 Hx Bio Ventures invests in early-stage companies developing next-generation biologics.See details»

Hx Bio Ventures โ€“ ABALOS THERAPEUTICS

Hx Bio Ventures invests into early stage companies developing next generation biologics. It is Hxโ€™s mission to help exceptional entrepreneurs building the next generation of great biotech companies. With a clear focus on & know how in โ€ฆSee details»

Abalos Therapeutics Completes Series A Extension Bringing Total โ€ฆ

The extension was led by Seventure Partners with support from Coparion, Ventura BioMed Investors and Hx Bio Ventures as well as contributions from existing investors from the initial โ€ฆSee details»

Hx Bio Ventures Portfolio Investments, Hx Bio Ventures Funds, Hx โ€ฆ

Hx Bio Ventures invests into early stage companies developing next generation biologics. Use the CB Insights Platform to explore Hx Bio Ventures's full profile.See details»

Hx Bio invests in Abalos Therapeutics to develop an arenavirus โ€ฆ

Oct 14, 2021 For more information, please visit www.abalosu0002tx.com. Hx Bio Ventures invests into early-stage biotech companies developing next generation vaccines and โ€ฆSee details»

Dr. Juri Bach โ€“ ABALOS THERAPEUTICS

Among other functions, he manages the activities of Hx Bio Ventures investing into biotech companies with a focus on biologics. He has several yearsโ€™ experience as a venture capitalists in life science as well as operations in the โ€ฆSee details»

Mario Nawfal - Wikitia

Aug 15, 2023 Mario Nawfal (born May 8th, 1994) is a serial entrepreneur, angel investor, and international speaker based in Dubai. He currently serves as the Chairman of the Athena Group of Companies. [1] Nawfal is also the founder of โ€ฆSee details»

Team - HX Venture Fund

Aleece Hobson is a Venture Partner leading the activation efforts at HX Venture Fund in Houston, Texas. She is responsible for connecting VCs, Houston startups, and the firmโ€™s Limited โ€ฆSee details»

Hx Bio Ventures B.V. | Creditsafe

Hx Bio Ventures B.V. ist in der Branche Finanzholdinggesellschaften tätig. Das Unternehmen wurde am 2021 eingetragen. Der Hauptsitz befindet sich hier: J.h. Oortweg 15, 2333 CH, โ€ฆSee details»

HX Venture Fund - Crunchbase Investor Profile

HX Venture Fund is a venture capital fund of funds that leverages the transformational power of enterprises and high-growth startups.See details»

Sandy Guitar โ€” Texas Venture Alliance

Feb 26, 2023 Sandy is a Managing Director of HX Venture Fund, a venture capital fund of funds focused on producing superior returns for its Limited Partners and on developing the startup โ€ฆSee details»

Capital BioVentures Announces Inaugural Cohort for Ottawa โ€ฆ

Dec 3, 2024 Capital BioVentures is a not-for-profit biotech accelerator located in Ottawa that offers early-stage funding and resources to Canadian companies. The organization provides โ€ฆSee details»

HX Venture Fund expands its portfolio and team after reaching โ€ฆ

Jun 4, 2020 The HX Venture Fund was founded in October of 2018 to encourage investment into local startups by raising corporate funds and investing into a portfolio of non-Houston โ€ฆSee details»

Working at BIO Ventures for Global Health | Glassdoor

See what employees say it's like to work at BIO Ventures for Global Health. Salaries, reviews, and more - all posted by employees working at BIO Ventures for Global Health.See details»

BIO Ventures for Global Health | Clinical Trial Community ... - CTCAN

BIO Ventures for Global Health (BVGH) is a non-profit organization based in Seattle, USA that forges and manages multinational public-private partnerships across infectious and non โ€ฆSee details»

Bioqube Ventures hiring Office Manager / Executive Assistant

Debora Dumont Bioqube Ventures is an early-stage global life sciences investment firm with offices in Belgium (Antwerp/Hasselt) and the US (San Diego). We source, finance and develop โ€ฆSee details»

HX Venture Fund - Contacts, Employees, Board Members

HX Venture Fund is a venture capital fund of funds that leverages the transformational power of enterprises and high-growth startups.See details»

US AI Regulations vs. The EU AI Act - DataCamp

AI regulations are becoming a major component of technology governance, affecting many businesses around the world. The EU AI Act is the most comprehensive and wide ranging, but โ€ฆSee details»

Michael Saylor Net Worth: The Crypto Visionaryโ€™s Wealth and Assets

Mar 12, 2025 Beyond his corporate ventures, Saylor founded Saylor Academy, a non-profit organization that provides free online education worldwide. This initiative underscores Saylorโ€™s โ€ฆSee details»

linkstock.net © 2022. All rights reserved